Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
CIPN (Chemotherapy-Induced Peripheral Neuropathy) Group:
- People aged 18 to 80 years
- People who have previously been treated with platinum- or taxane-based chemotherapy
- People who have had tingling, burning, or abnormal sensations in their hands and/or feet (like wearing invisible gloves or stockings) for at least 3 months, starting after their chemotherapy treatment
- People whose worst nerve-related pain has been rated at least 4 out of 10 in the past week
Registry Group (comparison group with no current symptoms):
- People aged 18 to 80 years
- People who have previously been treated with platinum- or taxane-based chemotherapy
- People who currently have no nerve-related symptoms as described above
Who may not be able to join:
- People with an unstable heart condition or a known irregular heartbeat
- People who have had head or neck cancer, or cancer that has spread to the head or neck
- People who have recently had an ear injury or have an active skin condition at the area where the device would be placed
- People who finished cancer treatment or surgery less than 2 months ago
- People who have metal implants in the head or neck (for example, a cochlear implant)
- People who have an implanted electronic device (for example, a pacemaker)
- People with a known allergy to tape or adhesives
- People with a history of seizures or epilepsy, a brain condition, or a defect in the skull
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marlon L Marlon, PT, PhD, University of Miami
Phone: 3052842359
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Retention Rate (taVNS Intervention Cohort); Retention Rate (Prospective Registry Cohort); Recruitment Rate (taVNS Intervention Cohort); Acceptability (taVNS Intervention Cohort); Treatment Adherence (taVNS Intervention Cohort)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.